Brief: Corline Biomedical Q4 Operating Loss Widens To SEK 2.1 Mln
Feb 25 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q4 NET SALES SEK 0.4 MILLION VERSUS SEK 0.5 MILLION YEAR
AGO
* Q4 OPERATING LOSS SEK 2.1 MILLION VERSUS LOSS SEK 1.7
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE20dL3B
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln